Table 2 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://figshare.com/articles/dataset/Table_2_from_A_Phase_IB_Study_of_Binimetinib_and_Palbociclib_in_Molecularly_Selected_Advanced_Triple-Negative_Breast_Cancer/30233481
下载链接
链接失效反馈官方服务：
资源简介：
Adverse events grade 2 or higher attributed to palbociclib and binimetinib (>5% of the patients).
创建时间：
2025-09-29
